[1] |
Xu Liangrun, Yang Mingying, Guo Yingwu, Wang Yun, Xu Jingjing, Hou Juyan, Ma Yunhong.
Effect of family collaborative care model in self-management of new smear-positive tuberculosis patients under the health belief model collaborative
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 210-217.
|
[2] |
Zhang Han, Wang Lixia, Wei Yushi, Zhao Rui, Wang Xinqi, Liu Nianqiang, Wang Senlu.
Evaluation of the application effect of digital therapeutics adherence technology in medication management of tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2024, 46(2): 158-164.
|
[3] |
Li Yamin, Gao Zhidong, Li Yanyuan, Tao Liying, Zhao Xin.
Effectiveness of WeChat and electronic pillbox in strengthening supervision management for pulmonary tuberculosis patients in Beijing
[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 872-879.
|
[4] |
XUE Xiao, ZHANG Dong-yan, AI Ping, DENG Ling, CHEN Wei, HU Yuan-lian, JIA Xue-jiao, YANG Guo-liang, XIN Zhen-jiang, CHANG Li-jie.
Analysis of the usage of electronic pillbox and WeChat App in pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2022, 44(7): 704-710.
|
[5] |
HU Yuan-lian, DENG Ling, AI Ping, JIA Xue-jiao, CHEN Wei, ZHANG Dong-yan, XUE Xiao, WU Qian-yu, XIE Jun-qing.
Survey on the community treatment and management of pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2022, 44(5): 473-477.
|
[6] |
TIAN Xiao-mei, LEI Juan, LIU Jing, LIU Guang-tian, PAN Li, LIU Tao, SHI Feng, WANG Xiao-lin.
Analysis on the effect of diagnosis and treatment management of rifampicin-resistant pulmonary tuberculosis and financing mode in Ningxia
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 772-777.
|
[7] |
ZHOU Shuang, CHEN Nan, ZHU Kun, JIANG Hui, YANG Lei, DU Jian.
Investigation of the experience of tuberculosis patients for follow up using the internet platform
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 398-403.
|
[8] |
KUANG Hao-bin, XIE Yu-hong, FENG Zhi-yu, QIN Hong-juan, LIAO Ya-yi, WANG Min, ZHANG Hong, YUANG Yuan, WU Di, CHEN Ze-ying, TAN Shou-yong.
Analysis on the effect of management strategies for multidrug-resistant tuberculosis in Guangzhou from 2014-2019
[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 113-118.
|
[9] |
ZHONG Qian-hong, MA Xiao-hui, LIN Zhi-hao, LI Yi, ZHOU Jie, DENG Dong-hua, DENG Ci-xi, LIANG Xiao-min.
Evaluation of the application of Foshan Tuberculosis Surveillance and Management Platform in tuberculosis prevention and treatment
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 653-656.
|
[10] |
WANG Ni, ZHANG Hui, ZHANG Tie-juan, CHEN Bin, LEI Juan, SUN Miao-miao, HUANG Fei.
Analysis of using electronic pillbox to assist the medication management of pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 682-686.
|
[11] |
FANG Xue-e, CHEN Dan-ping, TANG Ling-ling, FAN Lin, CHEN Wei, JI Hai-ming, MAO Yan-jun.
Application effect of individual case management model during the process of taking bedaquiline in patients with MDR-PTB
[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 641-644.
|
[12] |
LI Ya-min, GAO Zhi-dong, CHEN Xi, ZHAO Xin, TAO Li-ying, LI Yan-yuan.
Investigation of the acceptance of mobile internet technology for the health management of tuberculosis patients in the community
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1313-1317.
|
[13] |
Zhi LI,Hui ZHOU,Xiao-jun CHEN,Li-jie ZHANG,Sen-lu WANG,Hui ZHANG,Xiao-qiu LIU.
A review of research progress on the management of tuberculosis patients based on digital technology
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 1015-1020.
|
[14] |
Xiao-ying JIANG,Shi-wen JIANG,Meng-qiu GAO,Wen ZHANG,Zhi-guo ZHANG,Zhi-dong GAO,Hong ZHANG,Jian DU,Fei-fei NIE,Hui ZHANG,Hong-fei DUAN,Feng-ling MI.
Suggestions on infection control of active pulmonary tuberculosis patients treated at home
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 920-925.
|
[15] |
Dong-mei HU,Xue LI,Xiao-qiu LIU,Cai-hong XU.
Survey on the treatment and management of tuberculosis patients in China in 2018
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 930-935.
|